Mereo BioPharma Group plc (MREO) Misses Q2 EPS by 1c

Mereo BioPharma Group plc (NASDAQ: MREO) reported Q2 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01).

For earnings history and earnings-related data on Mereo BioPharma Group plc (MREO) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Reading (RDI) Tops Q2 EPS by 4c